Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “George is good at everything as a specialist in those areas. He isn’t frightened by going where no-one has gone before and is very solution-oriented. He can lay out diagrams/menus/ procedures to follow and it works.”

    -Chambers 2012

  • “A strong lawyer…"

    -Chambers 2012

  • “She is very competent in advising us on the deal – many of us didn’t realize the significance or the terminology. She is very thorough and is very good at explaining how the deals worked and what it was.”

    -Chambers 2012

  • “He has a good sense of helping a lender to reduce risk on business points. He talks through changes and their effect. He has really good perspective about documentation and ensuing risk.”

    -Chambers 2012

  • “John Kavanagh and Ed Bowron did an excellent job."

    -Chambers 2012